Developing a platform dedicated to the research and development of new drugs for the treatment of degenerative diseases of the central nervous system, such as Alzheimer's, and oncology: this is the goal of the NeOn Project, which started after the agreement signed in Milan at the Dompé headquarters.
The biopharmaceutical company is the leader of a real "scientific consortium" that brings together organizations and companies among the highest levels of excellence in their respective areas of expertise. Among these, the Vita-Salute San Raffaele University, together with the University and Polytechnic of Milan, the European Institute of Oncology, the CNR Institute of Neuroscience, the Italian Institute of Technology, and the companies Proxentia srl and Neuro-zone srl.
“A virtuous example of how public and private come together to create excellence, for the local area and for patients”, said Sergio Dompé, President and CEO of Dompé Pharmaceuticals. "With 28 thousand employees in the sector, the Lombardy Region is the hub of the activity of centers of excellence recognized worldwide with which we will work to identify new therapeutic solutions".